ABH Healthcare Limited (NSE:ABH)
41.45
+0.15 (0.36%)
At close: Oct 1, 2026
ABH Healthcare Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 30.27 | 6.11 | 0.16 | 1.52 | - |
Cash & Short-Term Investments | 30.27 | 6.11 | 0.16 | 1.52 | - |
Cash Growth | 395.37% | 3695.03% | -89.38% | - | - |
Receivables | 331.09 | 197.36 | 119.79 | 58.93 | 10.52 |
Inventory | 32.5 | 44.58 | 28.91 | 22.59 | 20.09 |
Other Current Assets | 21.58 | 18.1 | 22.33 | 11.18 | 2.65 |
Total Current Assets | 415.44 | 266.15 | 171.18 | 94.21 | 33.26 |
Property, Plant & Equipment | 418.47 | 365.89 | 337.53 | 234.17 | 235.5 |
Goodwill | 0.5 | 0.5 | - | - | - |
Other Intangible Assets | 0.22 | 0.4 | 0.58 | - | - |
Other Long-Term Assets | 18.11 | 6.1 | 4.17 | 4.18 | 1.3 |
Total Assets | 852.73 | 639.04 | 513.46 | 332.56 | 270.05 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 65.96 | 67.77 | 55.72 | 33.18 | 38.12 |
Accrued Expenses | 7.46 | 13.48 | 19.74 | - | - |
Short-Term Debt | 36.03 | 92.21 | 69.95 | 44.55 | 37.41 |
Current Portion of Long-Term Debt | 30.41 | 37.57 | 42.59 | - | - |
Current Income Taxes Payable | - | - | - | 2.1 | 0.58 |
Other Current Liabilities | 1.54 | 0.51 | 1.52 | 18.34 | 11.51 |
Total Current Liabilities | 141.39 | 211.54 | 189.53 | 98.17 | 87.62 |
Long-Term Debt | 483.93 | 289.02 | 245.32 | 181.14 | 179.78 |
Pension & Post-Retirement Benefits | 6.1 | 4.9 | 2.84 | - | - |
Long-Term Deferred Tax Liabilities | 18.76 | 13.08 | 7.24 | 5.04 | - |
Other Long-Term Liabilities | 29.16 | 3.5 | 5 | 0 | -0 |
Total Liabilities | 679.34 | 522.04 | 449.93 | 284.36 | 267.4 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 80 | 20 | 20 | 20 | 1 |
Additional Paid-In Capital | - | 19 | 19 | 19 | - |
Retained Earnings | 93.37 | 77.92 | 24.53 | 9.2 | 1.65 |
Total Common Equity | 173.37 | 116.92 | 63.53 | 48.2 | 2.65 |
Minority Interest | 0.02 | 0.08 | - | - | - |
Shareholders' Equity | 173.39 | 117 | 63.53 | 48.2 | 2.65 |
Total Liabilities & Equity | 852.73 | 639.04 | 513.46 | 332.56 | 270.05 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 550.37 | 418.79 | 357.86 | 225.69 | 217.19 |
Net Cash (Debt) | -520.11 | -412.68 | -357.7 | -224.18 | -217.19 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -65.01 | -51.59 | -44.71 | -29.68 | -542.83 |
Filing Date Shares Outstanding | 11.43 | 8 | 8 | 8 | 0.4 |
Total Common Shares Outstanding | 8 | 8 | 8 | 8 | 0.4 |
Working Capital | 274.05 | 54.62 | -18.34 | -3.96 | -54.37 |
Book Value Per Share | 21.67 | 14.61 | 7.94 | 6.03 | 6.62 |
Tangible Book Value | 172.65 | 116.02 | 62.95 | 48.2 | 2.65 |
Tangible Book Value Per Share | 21.58 | 14.50 | 7.87 | 6.03 | 6.62 |
Buildings | 164.08 | 158.36 | 131.47 | - | - |
Machinery | 325.11 | 259.19 | 236.86 | - | - |